156 related articles for article (PubMed ID: 33288565)
1. Anticancer Efficacy and Mechanism of Amentoflavone for Sensitizing Oral Squamous Cell Carcinoma to Cisplatin.
Chen CH; Huang YC; Lee YH; Tan ZL; Tsai CJ; Chuang YC; Tu HF; Liu TC; Hsu FT
Anticancer Res; 2020 Dec; 40(12):6723-6732. PubMed ID: 33288565
[TBL] [Abstract][Full Text] [Related]
2. Amentoflavone Induces Cell-cycle Arrest, Apoptosis, and Invasion Inhibition in Non-small Cell Lung Cancer Cells.
Chen WT; Chen CH; Su HT; Yueh PF; Hsu FT; Chiang IT
Anticancer Res; 2021 Mar; 41(3):1357-1364. PubMed ID: 33788727
[TBL] [Abstract][Full Text] [Related]
3. Reinforcement of Sorafenib Anti-osteosarcoma Effect by Amentoflavone Is Associated With the Induction of Apoptosis and Inactivation of ERK/NF-κB.
Su CM; Li CH; Huang MC; Yueh PF; Hsu FT; Lin RF; Hsu LC
In Vivo; 2022; 36(3):1136-1143. PubMed ID: 35478108
[TBL] [Abstract][Full Text] [Related]
4. Neuropilin-1 promotes epithelial-to-mesenchymal transition by stimulating nuclear factor-kappa B and is associated with poor prognosis in human oral squamous cell carcinoma.
Chu W; Song X; Yang X; Ma L; Zhu J; He M; Wang Z; Wu Y
PLoS One; 2014; 9(7):e101931. PubMed ID: 24999732
[TBL] [Abstract][Full Text] [Related]
5. HOXA1 silencing inhibits cisplatin resistance of oral squamous cell carcinoma cells via IκB/NF-κB signaling pathway.
Zhu R; Mao Y; Xu X; Li Y; Zheng J
Anticancer Drugs; 2024 Jul; 35(6):492-500. PubMed ID: 38477942
[TBL] [Abstract][Full Text] [Related]
6. Amentoflavone Inhibits ERK-modulated Tumor Progression in Hepatocellular Carcinoma
Lee KC; Tsai JJ; Tseng CW; Kuo YC; Chuang YC; Lin SS; Hsu FT
In Vivo; 2018; 32(3):549-554. PubMed ID: 29695559
[TBL] [Abstract][Full Text] [Related]
7. Amentoflavone Inhibits Metastatic Potential Through Suppression of ERK/NF-κB Activation in Osteosarcoma U2OS Cells.
Pan PJ; Tsai JJ; Liu YC
Anticancer Res; 2017 Sep; 37(9):4911-4918. PubMed ID: 28870912
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin induces apoptosis in oral squamous carcinoma cells by the mitochondria-mediated but not the NF-kappaB-suppressed pathway.
Azuma M; Tamatani T; Ashida Y; Takashima R; Harada K; Sato M
Oral Oncol; 2003 Apr; 39(3):282-9. PubMed ID: 12618201
[TBL] [Abstract][Full Text] [Related]
9. Amentoflavone Induces Anti-angiogenic and Anti-metastatic Effects Through Suppression of NF-κB Activation in MCF-7 cells.
Chen JH; Chen WL; Liu YC
Anticancer Res; 2015 Dec; 35(12):6685-93. PubMed ID: 26637885
[TBL] [Abstract][Full Text] [Related]
10. Loss of Tumor Suppressor CYLD Expression Triggers Cisplatin Resistance in Oral Squamous Cell Carcinoma.
Suenaga N; Kuramitsu M; Komure K; Kanemaru A; Takano K; Ozeki K; Nishimura Y; Yoshida R; Nakayama H; Shinriki S; Saito H; Jono H
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635163
[TBL] [Abstract][Full Text] [Related]
11. Amentoflavone Effectively Blocked the Tumor Progression of Glioblastoma via Suppression of ERK/NF-
Hsu FT; Chiang IT; Kuo YC; Hsia TC; Lin CC; Liu YC; Chung JG
Am J Chin Med; 2019; 47(4):913-931. PubMed ID: 31096773
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of NF-κB suppresses bone invasion by oral squamous cell carcinoma in vivo.
Furuta H; Osawa K; Shin M; Ishikawa A; Matsuo K; Khan M; Aoki K; Ohya K; Okamoto M; Tominaga K; Takahashi T; Nakanishi O; Jimi E
Int J Cancer; 2012 Sep; 131(5):E625-35. PubMed ID: 22262470
[TBL] [Abstract][Full Text] [Related]
13. Effect of verbascoside on apoptosis and metastasis in human oral squamous cell carcinoma.
Zhang Y; Yuan Y; Wu H; Xie Z; Wu Y; Song X; Wang J; Shu W; Xu J; Liu B; Wan L; Yan Y; Ding X; Shi X; Pan Y; Li X; Yang J; Zhao X; Wang L
Int J Cancer; 2018 Aug; 143(4):980-991. PubMed ID: 29536537
[TBL] [Abstract][Full Text] [Related]
14. Amentoflavone Enhances the Therapeutic Efficacy of Sorafenib by Inhibiting Anti-apoptotic Potential and Potentiating Apoptosis in Hepatocellular Carcinoma
Tsai JJ; Hsu FT; Pan PJ; Chen CW; Kuo YC
Anticancer Res; 2018 Apr; 38(4):2119-2125. PubMed ID: 29599330
[TBL] [Abstract][Full Text] [Related]
15. Amentoflavone Induces Apoptosis and Inhibits NF-ĸB-modulated Anti-apoptotic Signaling in Glioblastoma Cells.
Yen TH; Hsieh CL; Liu TT; Huang CS; Chen YC; Chuang YC; Lin SS; Hsu FT
In Vivo; 2018; 32(2):279-285. PubMed ID: 29475910
[TBL] [Abstract][Full Text] [Related]
16. CARD9 downregulation suppresses the growth of oral squamous cell carcinoma by regulating NF-κB.
Ye LJ; Zhou XC; Yin XJ; Shang Y; Xiao Y; Jiang YL; Wen XX
Oral Dis; 2019 Nov; 25(8):1886-1896. PubMed ID: 31306536
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effect of sorafenib with ionizing radiation on human oral cancer cells.
Hsu FT; Chang B; Chiang IT; Wu TH; Hwang JJ
In Vivo; 2014; 28(5):925-33. PubMed ID: 25189909
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting the PI3K/Akt, NF-κB signalling pathways with syringic acid for attenuating the development of oral squamous cell carcinoma cells SCC131.
Velu P; Vijayalakshmi A; Vinothkumar V
J Pharm Pharmacol; 2020 Nov; 72(11):1595-1606. PubMed ID: 32790092
[TBL] [Abstract][Full Text] [Related]
19. Suppression of ERK/NF-κB Activation Is Associated With Amentoflavone-Inhibited Osteosarcoma Progression
Lee YJ; Chung JG; Chien YT; Lin SS; Hsu FT
Anticancer Res; 2019 Jul; 39(7):3669-3675. PubMed ID: 31262893
[TBL] [Abstract][Full Text] [Related]
20. Alkannin restrains oral squamous carcinoma cell growth, migration and invasion by regulating microRNA-9/RECK axis.
Mao Y; Zhang W; Zhang R; Zuo J
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3153-3162. PubMed ID: 31349748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]